Page 34 - Read Online

Briz et al. Liver cancer chemoresistance

inhibitor pretreatment on resistance of solid tumors to cytotoxic epithelial-mesenchymal transition and chemoresistance in biliary
drugs. J Natl Cancer Inst 2004;96:1702-13. tract cancer. Eur J Cancer 2013;49:1725-40.
13. Fais S, Venturi G, Gatenby B. Microenvironmental acidosis in 21. Ju BL, Chen YB, Zhang WY, Yu CH, Zhu DQ, Jin J. miR-145
carcinogenesis and metastases: new strategies in prevention and regulates chemoresistance in hepatocellular carcinoma via epithelial
therapy. Cancer Metastasis Rev 2014;33:1095-108. mesenchymal transition. Cell Mol Biol (Noisy-le-grand) 2015;61:12-6.
14. Taylor S, Spugnini EP, Assaraf YG, Azzarito T, Rauch C, Fais 22. Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu
S. Microenvironment acidity as a major determinant of tumor CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY,
chemoresistance: proton pump inhibitors (PPIs) as a novel Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT. MicroRNA-
therapeutic approach. Drug Resist Updat 2015;23:69-78. 125b attenuates epithelial-mesenchymal transitions and targets stem-
15. Ferrari S, Perut F, Fagioli F, Brach Del Prever A, Meazza C, like liver cancer cells through small mothers against decapentaplegic
Parafioriti A, Picci P, Gambarotti M, Avnet S, Baldini N, Fais S. 2 and 4. Hepatology 2015;62:801-15.
Proton pump inhibitor chemosensitization in human osteosarcoma: 23. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, Lanuti M,
from the bench to the patients’ bed. J Transl Med 2013;11:268. Tanabe KK. Epithelial-to-mesenchymal transition and integrin-
16. Brivio S, Cadamuro M, Fabris L, Strazzabosco M. Epithelial-to- linked kinase mediate sensitivity to epidermal growth factor receptor
mesenchymal transition and cancer invasiveness: what can we learn inhibition in human hepatoma cells. Cancer Res 2008;68:2391-9.
from cholangiocarcinoma? J Clin Med 2015;4:2028-41. 24. Castillo J, Erroba E, Perugorria MJ, Santamaria M, Lee DC, Prieto J,
17. Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA, Wu J. Epithelial Avila MA, Berasain C. Amphiregulin contributes to the transformed
mesenchymal transition and hedgehog signaling activation are phenotype of human hepatocellular carcinoma cells. Cancer Res
associated with chemoresistance and invasion of hepatoma 2006;66:6129-38.
subpopulations. J Hepatol 2011;55:838-45. 25. Zhang PF, Li KS, Shen YH, Gao PT, Dong ZR, Cai JB, Zhang C,
18. Huang XY, Ke AW, Shi GM, Zhang X, Zhang C, Shi YH, Wang XY, Huang XY, Tian MX, Hu ZQ, Gao DM, Fan J, Ke AW, Shi GM.
Ding ZB, Xiao YS, Yan J, Qiu SJ, Fan J, Zhou J. alphaB-crystallin Galectin-1 induces hepatocellular carcinoma EMT and sorafenib
complexes with 14-3-3zeta to induce epithelial-mesenchymal resistance by activating FAK/PI3K/AKT signaling. Cell Death Dis
transition and resistance to sorafenib in hepatocellular carcinoma. 2016;7:e2201.
Hepatology 2013;57:2235-47. 26. Lee D, Na J, Ryu J, Kim HJ, Nam SH, Kang M, Jung JW, Lee MS,
19. Fernando J, Malfettone A, Cepeda EB, Vilarrasa-Blasi R, Bertran E, Song HE, Choi J, Lee GH, Kim TY, Chung JK, Park KH, Kim SH,
Raimondi G, Fabra A, Alvarez-Barrientos A, Fernandez-Salguero Kim H, Seo H, Kim P, Youn H, Lee JW. Interaction of tetraspan(in)
P, Fernandez-Rodriguez CM, Giannelli G, Sancho P, Fabregat I. A TM4SF5 with CD44 promotes self-renewal and circulating capacities
mesenchymal-like phenotype and expression of CD44 predict lack of hepatocarcinoma cells. Hepatology 2015;61:1978-97.
of apoptotic response to sorafenib in liver tumor cells. Int J Cancer 27. Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi
2015;136:E161-72. T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita
20. Yamada D, Kobayashi S, Wada H, Kawamoto K, Marubashi S, N, Yoshimori T, Hayashi N. Inhibition of autophagy potentiates
Eguchi H, Ishii H, Nagano H, Doki Y, Mori M. Role of crosstalk the antitumor effect of the multikinase inhibitor sorafenib in
between interleukin-6 and transforming growth factor-beta 1 in hepatocellular carcinoma. Int J Cancer 2012;131:548-57.

26 Hepatoma Research ¦ Volume 3 ¦ January 19, 2017